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ABSTRACT  
Extensive worldwide research on diabetes has established the complexities of 
the relationship between stress and diabetes. Evidence suggests that stress can 
affect diabetes, in terms of both its onset and exacerbation. Stress can have a 
deleterious effect on glycaemic control and can affect quality of life in diabetics. 
On the other hand emerging evidence strongly suggests that interventions that 
help individuals prevent or cope with stress can have an important positive 
effect on quality of life and glycaemic control. 
In this clinical study we have approached to assess the different stresses like 
Emotional burden, Physician related distress, Regimen related distress & 
Interpersonal distress in Type – 2 diabetic populations with Diabetes Distress 
Scale (DDS). Those diabetics having a considerable stress level (DDS Score > 3) 
were given treatment with Ashwagandha (Withania somnifera) capsules for six 
weeks and once again their stress level was reassessed. 
Ashwagandha significantly reduced the stress level and other stress related 
complains along with a better glycemic control as compared to placebo without 
any adverse effect. The positive effect of the drug also continued for another six 
weeks even after withdrawing the medication. 
Therefore Ashwagandha can offer comprehensive benefits as an adjuvant in 
Type – 2 diabetics suffering from stress. 
INTRODUCTION 
 The word “stress” is defined by the Oxford 
Dictionary as "a state of affair involving demand on 
physical or mental energy". In other words it is a state of 
mental or emotional strain or tension resulting from 
adverse or demanding circumstances. It is a condition or 
circumstance which can disturb the normal physiological 
and psychological functioning of an individual. In medical 
parlance “stress” is defined as a perturbation of the 
body’s homeostasis. This demand on mind & body occurs 
when it tries to cope with incessant changes in life. A 
“stress” condition seems “relative” in nature. Extreme 
stress conditions, psychologists say, are detrimental to 
human health but in moderation stress is normal and, in 
many cases, proves useful. [1] 
 Stress is basic elements of various human 
diseases and mental illness. Stress is a term that refers to 
the sum of the physical, mental, and emotional strains or 
tensions on a person. Stress is the "wear and tear" our 
mind and body experiences as we attempt to cope with 
our continually changing environment. Stress is also 
called as anxiety, tension etc. [2] 
 A stressor is defined as a stimulus or event that 
provokes a stress response in an organism. Stressors can 
be categorized as acute or chronic, and as external or 
internal to the organism.[3] 
 When stress occurs, the body prepares itself to 
take action. This preparation is called the fight-or-flight 
response. In the fight-or-flight response, levels of many 
hormones go higher than their normal concentration in 
the body. Their net effect is to make a lot of stored 
energy i.e. glucose and fat available to cells. These cells 
are then primed to help the body get away from danger. 
The initial stage of arousal remains the same whether we 
are faced with a major or minor stressor. But under 
extreme, prolonged, or persistent pressure the body 
continues to manufacture extra quantities of stress 
chemicals, triggering further processes to maintain 
energy. If arousal continues, the adrenal glands 
manufacture anti-inflammatory chemicals that 
simultaneously speed tissue repair while depressing the 
body’s immune defence system. If all these changes 
continue, the body goes on trying to adapt under 
increasing strain and pressure.[4] Eventually it breaks 
down. Exhaustion, variety of illnesses and even death 
may be the outcome of uninterrupted, excessive stress. [5] 
Ayurveda also emphasizes the psychosomatic basis of 
every disease condition which literally means any 
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problem of the body will cause a mental problem and 
vice versa. Similarly most of the diseases have their roots 
linked to both mind (Psyche - Mana) & body (Soma- 
Deha). 
 More recently, numerous studies have been 
performed, elucidating the role of emotional stress as a 
risk factor for the development of type - 2 diabetes. The 
majority of these studies focus on depression. However, 
there is growing evidence that other forms of emotional 
stress can contribute to the development of type- 2 
diabetes as well [6]. More over patient of diabetes may 
face stress at a single or multiple levels like physician 
related stress, regimen related stress, emotional stress, 
interpersonal stress etc. Not only the development or 
onset of Type - 2 DM but also stress affects diabetes 
control and care in many ways. Increased blood sugar 
level, increased insulin resistance, weight gain, 
compromised self care etc are but a few ways of 
intervention of stress to set up or complicate Type - 2 
DM. 
 Hence comprehensive diabetes care should also 
include stress management as a part of the program. 
Effective stress management will result in many positive 
outcomes in a patient of Type - 2 DM. It will not only 
keep the blood sugar and glycated haemoglobin (HbA1C) 
in the optimum level but also improve the quality of life 
in diabetics. 
 Stress management is one of the important 
therapeutic areas where Ayurveda has really gained 
ground. Ayurvedic way of stress management includes 
purificatory Panchakarma therapies, use of Rasayana 
ousadhis in the form of anti stress herbs, polyherbal & 
herbomineral compounds, adherence to right 
sociopersonal & behavioural conduct (Achara rasayana), 
practice of yoga and beneficial diets (Pathyahara). Many 
herbs possess proven antistress & adaptogenic 
properties.  
 Ashwagandha (Withania somnifera) is widely 
used as a Rasayana drug by Ayurvedic physicians for 
stress management. Many experimental & clinical trials 
have proved its antistress[7], adaptogenic[8], immuno-
modulatory[9], neurotrophic[10], anti-inflammatory[11] and 
antioxidant[12] properties of Ashwagandha. Its 
effectiveness and safety in different long term 
therapeutic use is beyond doubt. 
 In this study we have chosen Ashwagandha as 
the trial drug in the management of stress in type – 2 
diabetes patients as such type of specific studies are need 
of the hour. The results of the study are encouraging and 
it has added one more chapter to the therapeutic success 
of Ashwagandha. 
MATERIALS & METHODS 
 60 ambulatory patients were selected from the 
OPD of Gopabandhu Ayurveda Mahavidyalaya, Puri, 
Odisha during the period June 2012 to June 2013 after 
screening many Type-2 DM patients for their stress 
levels. Only patients with a considerable stress level 
(DDS17 Score ≥ 3 were registered. They were randomly 
allocated to the Trial Group (TG) & Control Group (CG). 
But during the study 2 patients from TG and 3 patients 
from CG dropped out from the study before completion 
due to some reason or the other. So the study was 
completed having 28 subjects in TG and 27 subjects in 
CG. This clinical study was conducted as per the Good 
Clinical Practice (GCP) guidelines and regulatory norms 
of India. The approval of the Institutional Ethical 
Committee (IEC) was obtained before starting the trial. 
Written informed consent was obtained from every 
patient as a prerequisite to be included in the trial. After 
registration, a primary screening and systemic 
examination was conducted for every patient and 
Laboratory investigations were done as per the protocol 
of the study. All these information were recorded in a 
well designed research case sheet. The patients were 
explained about the follow up schedule. 
Criteria for Inclusion 
 Already Diagnosed Type II Diabetics who are being 
treated with fixed Oral Hypoglycaemic allopathic 
drugs (Metformin 500 mg + Glimepride 1 mg) 
within the age group of 21 – 70 years 
 FBS ≥ 126 & ≤ 180 mg/dl and PPBS ≤ 240 mg/dl 
 HbA1C ≥ 7%  
 Mean Total DDS scoring ≥ 3 
Criteria for Exclusion 
 Diabetics on Insulin 
 Presence of major diabetic complications like 
nephropathy, retinopathy, neuropathy, ulcers 
 Gestational DM 
 Women planning pregnancy in next six months 
DDS17 Scoring 
 Diabetes Distress Scale (DDS) is a published & 
internationally accepted scale to measure different 
diabetes related psychosocial stress levels having 
seventeen questionnaires to be self answered by the 
patient.[13] 
Drug, Dosage & Duration 
 The patients of the trial group were given soft 
gelatine Ashwagandha (Withania somnifera) capsules 
containing 300 mg of root extract in ground nut oil base 
manufactured by Dabur India Limited as the trial drug in 
a dose of 1 cap b.i.d with a cup of Luke warm milk for a 
period of 6 weeks. 
 Placebo soft gelatine capsules containing only 
ground nut oil were given to the patients of control 
group in a dose of 1 cap b.i.d with a cup of Luke warm 
milk for six weeks. 
 The anti diabetic regimen for all the patients was 
kept fixed during the study period i.e. Metformin 500 mg 
+ Glimepride 1 mg, 1 tab bid. 
Duration of the Study and Follow up Schedule 
 Duration of the Study was 12 weeks. It included 
two phases. First six weeks were active treatment phase 
and the next six weeks were follow up phase after 
completion of active treatment. The follow up schedule 
was at the end of every 2 weeks i.e. end of 2nd, 4th, 6th, 
8th, 10th & 12th weeks. 
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Dietary & Exercise Regimen 
 Patients were advised to restrict their dietary 
schedule as per given instruction and do light exercise 
like brisk walking for 2 k.m. per day or swimming or 
jogging for half an hour per day etc. during treatment. All 
patients were advised to stop smoking, alcohol abuse or 
any other addiction completely. This information was 
provided to the patient in the form of an information 
booklet in regional language. 
Assessment Criteria 
Clinical Parameters 
 In clinical assessment DDS17 score was 
considered for measuring improvement in different 
psychosocial stress levels. Therefore DDS17 score was 
calculated at beginning and end of the study with the 
help of seventeen questionnaires to be self answered by 
the patient. 
Laboratory Investigations 
 FBS, PPBS, Lipid Profile, Urine – RE & ME, HbA1C 
tests were done at the beginning and end of the study in 
order to assess the blood sugar control and alteration in 
Lipid profile as both the trial drug and placebo contained 
ground nut oil. 
Reporting of Adverse Events 
 Adverse events if any with any of the patients 
either in trial or control group were recorded in every 
visit and they were compared with their baseline 
symptoms. Any reported adverse event was recorded 
carefully in the research case sheet. 
Statistical Analysis 
 The mean ± Standard Deviation (SD) was 
calculated for each subjective & objective parameter 
before and after treatment. The same was also calculated 
after the end of the follow up. Then Paired t-test was 
applied to test the significance of the outcomes. Finally 
the effectiveness of trial drug and control drug was 
accessed by calculating the p – value. All the statistical 
calculations were done using Graph Pad software. Data 
was presented in both tabular & graphical form under 
the guidance of a qualified statistician. 
OBSERVATION & RESULTS 
 It was observed that the sample size was 
dominated by males, patients within the age group of 41 
– 50 years, mixed non-vegetarians and tobacco users. It 
was also observed that there is a positive co-relation 
between obesity and diabetics under stress. 
Table1: Effectiveness of Trial & Control Drug on DDS Score 
 
Note : T (Trial Group), C (Control Group), SED (Standard Error of Deference), DF (Degree of Freedom), ES (Extremely 
Significant, S (Significant), NS (Not Significant) 
 The Emotional Burden, Regimen related distress, 
Interpersonal distress and total DDS score reduced 
in both the trial and control group after completion 
of the treatment. But the improvements were 
statistically significant in the trial group and not 
statistically significant in the control group taking 
placebo. 
 The Physician related distress reduced after 
treatment in both trial & control group as compared 
to before treatment scores. The change was 
extremely significant in trial group (TG) and very 
significant in control group (CG). 
 During the post treatment follow up phase (without 
giving any medicine or placebo) it was observed that 
the different elements of the DDS score did not 
change much in control group but they almost 
returned to their baseline values in the placebo 
controlled group. 
 
 
↑
Mean ± SD Mean ± SD ↓
T 28 4.12 ± 0.54 2.82 ± 0.61 ↓ 0.15 27 8.3 < 0.0001 ES
C 27 4.23 ± 0.57 4.13 ± 0.55 ↓ 0.05 26 1.95 0.0617 NS
T 28 4.16 ± 0.72 2.92 ± 0.96 ↓ 0.17 27 7.17 < 0.0001 ES
C 27 4.28 ± 0.65 4.02 ± 0.71 ↓ 0.08 26 3.11 0.0047 VS
T 28 4.5 ± 0.56 2.94 ± 0.78 ↓ 0.17 27 9.17 < 0.0001 ES
C 27 4.42 ± 0.58 4.4 ± 0.62 ↓ 0.06 26 0.38 0.7045 NS
T 28 4.6 ± 0.69 2.97 ± 1.24 ↓ 0.27 27 5.92 < 0.0001 ES
C 27 4.52 ± 0.71 4.44 ± 0.68 ↓ 0.07 26 1.06 0.2984 NS
T 28 4.33 ± 0.34 2.91 ± 0.47 ↓ 0.1 27 13.32 < 0.0001 ES
C 27 4.35 ± 0.39 4.24 ± 0.33 ↓ 0.1 26 1.11 0.271 NS
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Table 2: Effectiveness of Trial & Control Drug in Objective Parameters 
 
Note : T (Trial Group), C (Control Group), SED (Standard Error of Deference), DF (Degree of Freedom), ES (Extremely 
Significant, S (Significant), NS (Not Significant) 
 FBS was reduced significantly in both trial and 
control group. But the difference of mean FBS in 
before and after treatment was higher in trial 
group. 
 There was statistically significant reduction in PPBS 
in both the trial & control group. But the difference 
of mean PPBS in before and after treatment was 
higher in trial group. 
 The glycated haemoglobin (HbA1C) was also 
reduced significantly in both trial & control groups. 
But here also the difference of mean HbA1C in 
before and after treatment was higher in trial 
group. 
 The total cholesterol was also reduced in both the 
groups. However the change was extremely 
significant in trial group where as it was statistically 
not significant in control group and may be 
occurring by chance. 
DISCUSSION 
 The emotional burden, regimen related stress, 
interpersonal stress & total DDS Score reduced 
extremely significantly after treatment in the trial group 
but the change was not at all statistically significant in 
the Placebo controlled group.  
 Sitoindosides and acylsterylglucosides in 
Ashwagandha are anti-stress agents. Active principles of 
Ashwagandha, for instance the sitoindosides VII–X and 
Withaferin-A, have been shown to have significant anti-
stress activity against acute models of experimental 
stress [14]. This proves that these positive changes in 
different stress levels in trial group were due to some 
evidence based strong pharmacological actions of 
Ashwagandha like antistress, antidepressant, 
adaptogenic, anxiolytic, antioxidant etc and not due to 
any placebo effect. 
 The physician related stress was reduced in both 
trial & control groups extremely significantly & 
significantly respectively. This effect in the placebo 
treated control group might be due to the positive 
interaction of the patients with the physician, care & 
concern of the doctors shown to the patients but not due 
to any pharmacological action.  
 These effects of Ashwagandha were also long 
lasting and did not alter after stopping the medication 
during the follow up phase. 
 The FBS, PPBS & the HbA1c were significantly 
reduced after treatment showing good control of 
diabetes as both the groups were treated with fixed dose 
OHA (Glimepride 1 mg + Metformin 100 mg). But the 
control was little better in the trial group. This may be 
due to some proven anti diabetic effect of Ashwagandha 
[15]. Secondly the patients of the trial group improved 
significantly from stress after 6 weeks treatment with 
Ashwagandha capsules. This low level of stress must 
have helped the better overall diabetes control of the 
patients of the trial group than that of the group treated 
with placebo. 
 Since Ashwagandha soft gel capsule & placebo 
capsule contained ground nut oil, it was decided to keep 
a watch on the Lipid Profile of the patients. Surprisingly 
the total cholesterol was reduced significantly after 
treatment in the trial group. This effect of the trial drug 
may be due to hypolipidaemic effect of Ashwagandha. [15] 
 It was also lowered in the control group but the 
change may be occurring by chance and was not 
statistically significant. The safety of Ashwagandha has 
been proven beyond doubt by many experimental and 
clinical trials. 
 It is generally safe on long term therapeutic 
use.[16] It is usually very well tolerated by most of the 
patients. Therefore none of the patients in the trial group 
reported adverse effects of any kind during the study 
period. 
CONCLUSION 
 In summary, research has proved that stress has 
negative impact on diabetes. Stress has a role in the 
onset of diabetes and poor glycemic control affecting 
lifestyle. Interventions to manage stress in diabetics can 
↑
Mean ± SD Mean ± SD ↓
T 28 167.04 ± 8.94 129.86 ± 8.05 ↓ 1.87 27 19.84 < 0.0001 ES
C 27 164.7 ± 6.88 136.07 ± 9.32 ↓ 1.47 26 19.44 < 0.0001 ES
T 28 200.46 ± 10.87 141 ± 7.92 ↓ 1.71 27 34.72 < 0.0001 ES
C 27 204 ± 18.2 151.96 ± 11.23 ↓ 4.14 26 12.56 < 0.0001 ES
T 28 7.85 ± 0.49 6.8 ± 0.23 ↓ 0.09 27 11.25 < 0.0001 ES
C 27 7.73 ± 0.42 7.01 ± 0.39 ↓ 0.06 26 10.66 < 0.0001 ES
T 28 203.61 ± 20.77 193.94 ± 15.93 ↓ 1.35 27 7.18 < 0.0001 ES
C 27 205.12 ± 25.38 199.81 ± 24.1 ↓ 6.16 26 0.86 0.397 NS
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have an important positive effect on quality of life and 
glycemic control. [17] 
 Based on the findings of this study it can be 
broadly concluded beyond doubt that Ashwagandha 
(Withania somnifera) offers significant improvement in 
stress and related complains in patients of Type – 2 DM. 
Not only this but also it helps in over all control of 
diabetes and improves the quality of life in Type – 2 
diabetes Patients. The best part of the study is that 
Ashwagandha reduces stress level and other related 
complains without creating any undue effect. Ayurveda 
has included Ashwagandha in Rasayana Dravyas which 
can fight the disease and restore the health, vigour and 
vitality. There is a sea change in the management 
approach of Type – 2 DM. Not only controlling the blood 
glucose but also preventing complications and improving 
the quality of life have emerged as newer challenges for 
diabetologists. In this study Ashwagandha acted in 
multifaceted role to offer multiple benefits safely & 
economically. Therefore it can be prescribed as a therapy 
to diabetics with stress & as an adjuvant to other 
diabetics as well. 
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